Drug Shortage Report for SANDOZ DORZOLAMIDE/TIMOLOL
| Report ID | 270827 |
| Drug Identification Number | 02344351 |
| Brand name | SANDOZ DORZOLAMIDE/TIMOLOL |
| Common or Proper name | DORZOLAMIDE/TIMOLOL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DORZOLAMIDE TIMOLOL |
| Strength(s) | 20MG 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 10ML |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-11-03 |
| Estimated end date | 2025-11-28 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-11-04 | English | Compare |
| v2 | 2025-11-03 | French | Compare |
| v1 | 2025-11-03 | English | Compare |
Showing 1 to 3 of 3